Percutaneous implantation of the left ventricular partitioning device for chronic heart failure: a pilot study with 1-year follow-up


    loading  Checking for direct PDF access through Ovid

Abstract

AimsTo assess short-term safety defined as the successful delivery and deployment of the ventricular partitioning device (VPD) implant, as well as 12-month functional, clinical, and haemodynamic effectiveness.Methods and resultsVentricular partitioning device implantation was successful in 15/18 (83%) patients with anteroapical regional wall motion abnormalities following myocardial infarction. In one patient, the VPD was removed 3 days post implantation and the patient subsequently died due to extra-cardiac sepsis. When compared with baseline, there was significant improvement at 6 and 12 months following VPD implantation in NYHA class (2.21 ± 0.57 vs. 1.28 ± 0.46 vs. 1.23 ± 0.4.3, respectively, P < 0.001 for both), left ventricular (LV) end-systolic volume (189 ± 45 vs. 142 ± 29 vs. 151 ± 48 mL/m2, respectively, P < 0.001 for both), and LV end-diastolic volume (260 ± 47 vs. 208 ± 33 vs. 222 ± 58 mL/m2, respectively, P < 0.001 for both). After 12 months, an improvement in LV ejection fraction was noted (28 ± 7 vs. 32 ± 7 vs. 33 ± 9%, respectively, P = 0.02) as well as improvement in 6 min walk distance (382 ± 123 vs. 409 ± 7 vs. 425 ± 140 m) when compared with pre-procedural values.ConclusionOur data indicate that VPD implantation is safe and feasible, and that VPD implantation improves LV haemodynamics and functional capacity in the 12 months following the procedure.

    loading  Loading Related Articles